The clinical and Virology effects of NA inhibitor in influenza virus infections (age; over 4 years old, under 11 years old): an open-label, randomized study.

Trial Profile

The clinical and Virology effects of NA inhibitor in influenza virus infections (age; over 4 years old, under 11 years old): an open-label, randomized study.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Dec 2013

At a glance

  • Drugs Oseltamivir (Primary) ; Peramivir (Primary) ; Laninamivir; Zanamivir
  • Indications Influenza A virus H1N1 subtype; Influenza A virus H3N2 subtype
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top